Skip Navigation Bar

History of Medicine Finding Aids

Gorgas Memorial Institute of Tropical and Preventive Medicine Records 1899-1992
full text File Size: 197 K bytes | Add this to my bookbag

 
Box | Folder Title
 
Hypertension [H], 1939-96 [subseries]:


 
Saluretic Agents [H-1], 1953-91 [subseries]:


12 2-3
Chlorothiazide - Mechanism of action [34.1], 1957-89
12 4
Thiazide - Effects on LVH [34.2], 1982-87
12 5
Thiazide drugs [32], 1958-69, 1984
12 6
Mercurials [31], [after 1985]
12 7
Thiazides' effect on calcium [30], 1990-91
12 8
Aldosterone antagonists [29], 1953-80
12 9
Polythiazide [28], 1961-63
12 10
Non saluretic thiazides [27], 1961-68
12 11
Triamterene and MK870 [26], 1961-85
12 12
Furosemide [25], 1964-79
12 13
Ticrynafen [24], 1978-80
 
Blocking Agents [H-2], 1946-96 [subseries]:


12 14
Hexamethonium - Pharmacology [34A], 1950-60
12 15
Hexamethonium - Treatment, Clinical [34B], 1950-56
12 16
Hexamethonium and Hydralazine [34C], 1952-55
12 17
Hexamethonium and Rauwolfia [34D], 1953
12 18
Hexamethonium - Correspondence and reports [34E], 1951-64
12 19
Pentolinium - Pharmacology [33A], 1956-60
12 20
Pentolinium - Clinical [33B], 1953-56
12 21
Pentolinium - with Hydralazine [33C], 1955
12 22
Pentolinium - with Rauwolfia [33D], 1954-55
12 23
Pentolinium - Correspondence and reports [33E], 1954-55
12 24
Chlorisondamine - Pharmacology [32A], 1954-58
12 25
Chlorisondamine - Treatment [32B], 1955-57
12 26
Chlorisondamine - Correspondence and reports [32C], 1954-56
12 27
Mecamylamine [31], 1955-60
12 28
Miscellaneous blocking drugs - Arfonad [30], 1946-61
12 29
Ganglion blocking agents - Trimethidinium methosulfate [30], 1958-62
12 30
Pempidine [30], 1960
12 31-32
Guanethidine [29], 1959-76
12 33
Darenthin (or Bretylium) [28], 1959-62
12 34
Iproniazid and Catron [27], 1959-63
12 35
Pargyline [26], 1961-64
12 36
Ganglion blocking agents - Literature, side effects, toxicity, tolerance [25], 1948-63
12 37
Ganglion blocking agents - General chemical and pharmacological [25], 1947-63
12 38
Ganglion blocking agents - Clinical uses other than in hypertension [25], 1948-56
12 39
Sympatholytic, selective [23], 1960-66
12 40
General [22], 1948-74
12 41
Phentolamine (Regitine) [21], 1965
12 42-43
Adrenergic blockers - Various (includes Labetalol) [19], 1949-85
12 44
Aldomet [18], 1961-88
12 45-47
Beta adrenergic blockers [17], 1966-96
12 48-49
Propranolol [16], 1966-83
12 50
Angiotensin blockers - including Saralasin [15], 1984-95
12 51
Angiotensin blockers - Enalapril 421 or 521 [15A], 1978-90
12 52
Losartan [15B], 1992-95
13 1
Clonidine [14], 1975-85
13 2
Guanabenz [13], 1981-83
13 3
Thiocyanate [12], [after 1970]
13 4
Calcium Channel Block [7], 1995
13
Etiology and Pathogenesis [H-3], 1948-95 [subseries]:


13 5-6
Renin - Renal pressor theory [34], 1959-90
13 7
Kidney in [hypertension] - Pyelonephritis [33], 1959-70
13 8
Unilateral renal vascular disease [32], 1956-87
13 9
Renoprival [31], 1951-65
13 10
Renal, other [30], 1955-86
13 11-12
Salt in hypertension [29], 1955-87
13 13-14
K+ in diet and Na/K+ Ratio. Also, calcium [29A], 1975-88
13 15
Salt sensitivity - Potassium [29B], 1972-95
13 16
Neural [28], 1975-94
13 17
Baroreceptor theories [27], 1948-91
13 18
Sympathetic nerves [26], 1949-83
13 19
Brain and post, pituitary [25], 1958-88
13 20-21
Emotional stress - Neurogenic, other [ 24], 1950-86
13 22
Adrenal cortex [23], 1949-91
13 23
Hormonal, adrenal medulla [22], 1961-88
13 24
Pituitary in [hypertension] [21], 1948-50
13 25
Hormonal, other [20], 1955-82
13 26
Coarctation of aorta [19], 1951-88
13 27
Hypertension and heredity [18], 1953-87
13 28
Environment [17], 1957-77
13 29
Ca, Mg [16], 1985
13 30-31
Other ions than Na+ - Mg++, Ca++, K+, Cl [15], 1961-94
13 32-33
Fluid volumes in [hypertension] [14], 1952-93
13 34-38
Epidemiological studies [13], 1953-91
13 39-40
Epidemiology - Racial differences [13A], 1956-75
13 41
Exaggerated natriuresis in [hypertension] [12], 1949-62
13 42
Toxemia of pregnancy [11], 1964-84
13 43
Cardiogenic [10], 1962-84
14 1
Miscellaneous [9], 1962-87
14 2
History of hypertension [8] [photograph], [ca. 1960-64]
14 3
Reviews, general [7], 1976-80
14 4
Kallikrein and prostaglandins [6], 1968-85
14 5
Fast-twitch muscle fibers in hypertension - lower body compression [5], 1979-84
14 6
Atrial natriuretic factor [4], 1984-90
14 7
Insulin resistance diabetes [3], 1986-91
14 8
Obesity [3 - crossed out in index], 1987
14 9
Endothelium relaxing factor, etc. [2], 1989
 
Other Antihypertensive Agents, General Treatment Control Studies [H-4], 1940-96 [subseries]:


14 10
Hydralazine - Literature - Clinical [34], 1951-83
14 11
Hydralazine - Literature - Pharmacology [34], 1951-81
14 12
Hydralazine - Literature - Toxicity [34], 1953-82
14 13
Hydralazine - like agents [33], 1945-49
14 14
Rauwolfia - Side effects [32], 1954-83
14 15
Rauwolfia - Crude root [31], 1955-63
14 16
Reserpine - Pharmacology [29], 1954-77
14 17
Reserpine - Antiarrhythmic activity [29], 1955-66
14 18-19
Rauwolfia - Reserpine - Treatment [29], 1954-84
14 20
Rauwolfia - Various alkaloids [28], 1955-65
14 21
Veratrum - Pharmacology [27], 1949-66, 1983
14 22
Veratrum - Viride - Clinical treatment [26], 1948-54
14 23
Control studies [25], 1960-79, 1996
14 24
Veratrum - Other alkaloids - Protoveratrine, etc., Viscum album [24], 1949-59
14 25
Veratrum - Neogermitrine assay data [24], 1950
14 26
Sympathectomy [21], 1940-61
14 27
Miscellaneous [20], 1948-69
14 28
Azide Sodium - Literature [20], 1954-61
14 29
Hypertensive agent IN-66 (Irwin, Neisler and Co.) [20] [Restricted], 1952-1953
14 30
Adrenalectomy [19], 1951-54
14 31-34
Treatment Dietary [18], 1948-57, 1973-91
14 35
Surgery of renal hypertension [17], 1963
14 36
Renal transplants [16], 1964-65
14 37
Diazoxide [15], 1976
14 38
General discussion and review [14], 1974-81
14 39-40
Prazosin [13], 1974-95
14 41
Minoxidil [12], 1973-81
14 42
Cost of drugs [11], 1978-83
14 43-46
FDA and drug regulations [10], 1971-83
15 1
Psychophysiological techniques [9], 1972-84
15 2
National programs [8], 1977-82
15 3
Calcium antagonists - General [7A], 1977-92
15 4
Calcium antagonists - Nitrendipine [7C], [1984-85]
15 5
Calcium antagonists - Diltiazem [7D], 1982-89
15 6
Verapramil [7E], 1982-87
15 7
Exercise [6], 1978-86
15 8
Reverse titration [5], 1967-82
15 9
Serotonin antagonists [4], 1984-86
 
Clinical [H-5], 1943-93 [subseries]:


15 10
General discussion of disease - Reviews [34], 1946-50, 1970
15 11
Subarachnoid hemorrhage [33], 1982
15 12
Left Ventricular Hypertrophy / ECG or VCG in Hypertension [32], 1962-97
15 13
Prognosis, untreated [31], 1943-74
15 14
Treatment effect on prognosis - Indications for Rx mild [30], 1956-88
15 15
Prognosis with surgical [29], 1950-62
15 16
Reactivity in borderline hypertension [28], 1955-90
15 17
Practical details of drug treatment, home BPs, cost, etc. [27], 1974-88
15 18
Antihypertensive Drugs - Treatment, general [26], 1959-93
15 19
Systolic hypertension [25], 1982-88
15 20
Effects of Rx on organic damage (Cardiac, renal) [24] [photograph], 1951-91
15 21-22
Blood pressure recording [23], 1954-90
15 23
Blood pressure - Casual versus basal [22], 1953-89
15 24
Ambulatory BP monitoring [22A], 1981-90
15 25
Miscellaneous symptoms (Headache, etc.) [21], 1962, 1986-88
15 26
Uric acid, gout, gouty nephritis [20], 1963, 1966
15 27
Hypertensive encephalopathy and crisis [19], 1975-92
15 28
Dissecting aneurysm [18], 1968-82
15 29-30
Clinics for hypertension - Detection, costs [17], 1972-98
15 31
Hypertension in children [16], 1960-88
15 32
Physician education - Tests, nurse education, etc. [15], 1959-79
15 33
Hypertension in the aged [14], 1970-92
15 34-35
Obesity - Weight reduction [13], 1967-92
15 36
Comments on trials [12A], 1974-90
15 37-38
Compliance [11], 1967-87
15 39
Blacks and other race [10], 1976-89
15 40
Low lipid diets [9], 1981-87
15 41
Mental and behavioral [with and without] Rx [8], 1971-89
15 42
Stepdown of Rx [7], 1956, 1975-89
15 43
Left Ventricular Hypertrophy [6], 1979-94
15 44
The J curve [5], 1985-91
15 45
Circadian rhythm [4], 1992
15 46
Kidney in hypertension [3], 1988-92
15 47
Diabetes and HBP - Nephropathy [2], 1989-93
 
Atherosclerosis [H-6], 1949-93 [subseries]:


15 48
Atherosclerosis - Cholesterol in [34], 1957-89
15 49
Atherosclerosis and L[ow]-D[ensity] L[ipoproteins] [33], 1982
15 50
Atherosclerosis and dietary fat [32], 1955-90
15 51
Physical activity [31], 1960, 1981-87
15 52
Coronary [30], 1963-82
16 1
Lipids other than cholesterol [29], 1949-59, 1982
16 2
MER 29 - Cholesterol synthesis antagonists [28], 1960-62
16 3
Thyroid substances [27], 1949-57
16 4
Vessel wall factors [26], 1958-93
16 5-6
Miscellaneous drug treatment [25], 1957-91
16 7
Reviews [24], 1976-89
16 8-10
Epidemiology of coronary artery disease [23] [photographs], [1967]-88
16 11
By-pass surgery [22], 1977-90
16 12
Apolipoproteins [21], 1986
16 13
Blood clotting factors and prevention of M[yocardial] I[nfarction] [21], 1980-82
16 14
H[igh]-D[ensity] L[ipoprotein] [20], 1980-91
16 15
C[oronary] H[eart] D[isease] mortality - secondary prevention trials [19], 1984
16 16
Exercise [18], 1982-84
16 17
Acute Miyocardial] I[nfarction] [17], 1988-91
16 18
Hypertension and accelerated atherosclerosis [16] [photograph], 1960-82
16 19
Primary prevention control trials [15], 1984-91
16 20
Treatment of coronary occlusion with anticoagulants [14], 1985-90
16 21
Angina [13], 1984
16 22
Smoking [11], 1991
 
Organ Systems In and Types of Hypertension [H-7], 1939-89 [subseries]:


16 23
Malignant - Untreated [34], 1939, 1948-79
16 24
Malignant - Treated [33] [photographs], 1953-67
16 25
General [32], 1961
16 26
Kidney in [31], 1941-78
16 27
Heart in [30], 1958-89
16 28-29
Brain in [29], 1945-88
16 30
Large vessels in [28], 1955-88
16 31-32
Small vessels in [27], 1956-89
16 33
Other organs in [26], 1952-60
16 34-35
Pheochromocytoma [25], 1954-85
16 36
Fundi [24], 1962, 1980-85
16 37
Adrenal cortex in [23], 1941-75
16 38
Atherosclerosis in [22], 1959-87
16 39
Classification [21], 1946-58
16 40
S[pontaneously] H[ypertensive] R[at] [20], 1956-81
16 41
Veins - Venous tone [19], 1978-87
16 42
Vascular endothelium [18], [ca. 1980-89]